Human Biotechnology: Responding to Emerging Dangerous New Human Genetics
By Jesse Reynolds,
Z Magazine
| 03. 31. 2003
As 2003 began, the mainstream press was grappling with a cloning hoax. This January, it launched extended coverage of the 50th anniversary of the identification of DNA's structure. Both events provided golden opportunities to deepen public understanding of the social and political implications of new human genetic and reproductive technologies.
Unfortunately, the media have mostly flubbed these opportunities. The coverage of the Raelians' cloning claims obscured rather than illuminated the critical issues. Early signs on the second media opportunity-a series of carefully planned celebrations throughout the spring-are none too promising. Fortunately, a civil society response to dangerous new human genetic and reproductive technologies is emerging in a number of countries, as witnessed at January's World Social Forum in Brazil.
The year's first human biotechnology media frenzy actually began at the end of December 2002, when a previously obscure alien-chasing sect announced that its scientists had produced the world's first human clone. The initial news reaction appropriately focused on whether the claim could be true. But by the time the Raelians' excuses as to why they were unable to show the...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...